Standard Chemical & Pharmaceutical Co. Ltd.(TW:1720)
NT$55.20+0.20 (+0.36%)
TW:1720
Standard Chemical & Pharmaceutical Co. Ltd. financials statements
NT$55.20
At close:+0.20 (+0.36%)
Standard Chemical & Pharmaceutical Co. Ltd. (1720) Income Statement
Standard Chemical & Pharmaceutical Co. Ltd. Income Statement
Last quarter (Q2 2026), Standard Chemical & Pharmaceutical Co. Ltd.'s total revenue was NT$1.87B, an increase of 2.44% from the same quarter last year. In Q2, Standard Chemical & Pharmaceutical Co. Ltd.'s net income was NT$258.60M. See Standard Chemical & Pharmaceutical Co. Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 7.02B | NT$ 6.79B | NT$ 6.24B | NT$ 5.85B | NT$ 4.60B | |
| NT$ 2.91B | NT$ 2.99B | NT$ 2.73B | NT$ 2.49B | NT$ 2.07B | |
| NT$ 1.55B | NT$ 1.58B | NT$ 1.47B | NT$ 1.35B | NT$ 1.19B | |
| Depreciation and Amortization | NT$ 433.97M | NT$ 404.74M | NT$ 347.77M | NT$ 298.61M | NT$ 221.06M |
| NT$ 1.80B | NT$ 2.06B | NT$ 1.61B | NT$ 1.66B | NT$ 1.25B | |
| NT$ 1.36B | NT$ 1.40B | NT$ 1.26B | NT$ 1.44B | NT$ 1.02B | |
| NT$ 151.08M | NT$ 231.04M | NT$ 178.31M | NT$ 281.51M | NT$ 137.07M | |
| NT$ 1.51B | NT$ 1.63B | NT$ 1.44B | NT$ 1.40B | NT$ 1.01B | |
| NT$ 927.66M | NT$ 880.50M | NT$ 834.89M | NT$ 1.15B | NT$ 706.73M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 5.19 | NT$ 4.94 | NT$ 4.67 | NT$ 6.46 | NT$ 3.96 |
| Diluted EPS | NT$ 5.19 | NT$ 4.94 | NT$ 4.67 | NT$ 6.45 | NT$ 3.95 |
| Weighted Average Shares Outstanding | 241.91M | 178.70M | 178.78M | 178.70M | 178.70M |
| Weighted Average Shares Outstanding (Diluted) | 241.91M | 178.90M | 178.89M | 178.88M | 178.92M |
Currency in TWD
